Administration of cardiac mesenchymal cells modulates innate immunity in the acute phase of myocardial infarction in mice
Abstract Although cardiac mesenchymal cell (CMC) therapy mitigates post-infarct cardiac dysfunction, the underlying mechanisms remain unidentified. It is acknowledged that donor cells are neither appreciably retained nor meaningfully contribute to tissue regeneration—suggesting a paracrine-mediated...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/e60037ebf1604f059252e71ae039ca99 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!